Table 2:
Participant cancer and treatment characteristics by reproductive concerns. RCAC score > 3 indicates moderate to high reproductive concerns (N=747)
| Overall N=747 (%) |
RCAC > 3 N=328 (%) |
RCAC ≤ 3 N=419 (%) |
p-value | |
|---|---|---|---|---|
| Cancer Type | 0.87 | |||
| Thyroid, Skin, Melanoma | 218 (29.2) | 90 (27.4) | 128 (30.5) | |
| Breast | 156 (20.9) | 71 (21.7) | 85 (20.3) | |
| Cervix, Ovary, Uterus | 57 (7.6) | 25 (7.6) | 32 (7.6) | |
| Blood, Bone, Lymphoma, Sarcoma | 296 (39.6) | 134 (40.9) | 162 (38.7) | |
| Gastrointestinal | 20 (2.7) | 8 (2.4) | 12 (2.9) | |
| Years since cancer diagnosis | 0.01 | |||
| < 2 | 85 (11.4) | 49 (14.9) | 36 (8.6) | |
| 2–5 | 183 (24.5) | 86 (26.2) | 97 (23.2) | |
| > 5 | 479 (64.1) | 193 (58.8) | 286 (68.3) | |
| Age at cancer diagnosis | 0.13 | |||
| 15–20 | 157 (21.3) | 79 (24.5) | 78 (18.8) | |
| 21–30 | 371 (50.4) | 160 (49.7) | 211 (51.0) | |
| 31–35 | 208 (28.3) | 83 (25.8) | 125 (30.2) | |
| Cancer treatments | ||||
| Surgery | 0.14 | |||
| Yes | 500 (66.9) | 210 (64.0) | 290 (69.2) | |
| No | 247 (33.1) | 118 (36.0) | 129 (30.8) | |
| Chemotherapy | 0.03 | |||
| Yes | 455 (60.9) | 214 (65.2) | 241 (57.5) | |
| No | 292 (39.1) | 114 (34.8) | 178 (42.5) | |
| Radiation (excludes radioiodine) | 0.05 | |||
| Yes | 229 (30.7) | 113 (34.5) | 116 (27.7) | |
| No | 518 (69.3) | 215 (65.5) | 303 (72.3) | |
| Radioiodine | 0.83 | |||
| Yes | 130 (17.4) | 56 (17.1) | 74 (17.7) | |
| No | 617 (82.6) | 272 (82.9) | 345 (82.3) |
Note: Due to missing data, some variables do not add up to 747